Novartis to Acquire Promising Breast Cancer Drug in Up to $3 Billion Agreement
Swiss pharmaceutical company Novartis has announced an agreement to acquire a breast cancer drug candidate from U.S. biotech firm Synnovation Therapeutics for a total of up to $3 billion. This…